Melika Golmohammadi

Dr. Melika Golmohammadi


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2025 in Science Progress
Verified
Journal Article
Open access
MGMelika Golmohammadi
Melika Golmohammadi
PPParynaz Parhizgar
Parynaz Parhizgar
FGFarid Javandoust Gharehbagh
Farid Javandoust Gharehbagh
LLLegha Lotfollahi
Legha Lotfollahi
Objective: Finding accessible diagnostic tools for the diagnosis of atherosclerosis is necessary due to its rising incidence rate. The correlation of perirenal fat thickness (PRFT) and atherosclerosis has been investigated in previous studies using different imaging modalities including ultrasound and CT-scan, but their results have been equivocal. Therefore, we performed a systematic review and meta-analysis of observational studies to determine this potential correlation. Methods: This study is a systematic review and meta-analysis of observational studies. A comprehensive search was conducted up to 2 July 2024, across articles published in the Scopus, Web of Science, Cochrane Library, and PubMed databases. The protocol for this research has been registered in the PROSPERO international database under registration number CRD42024532843. Articles that examined the association between perirenal fat and atherosclerosis, and reported correlation coefficients (r), beta coefficients (β), and odds ratios (ORs) in cross-sectional and case-control designs, involving adult or pediatric human populations, were included. The pooled ORs (95% CI), the log OR, and its standard error were calculated. Results: Following the identification of 10 eligible articles, meta-analysis and subgroup analysis were performed for different conditions, including adults, children, gender, atherosclerosis site, and comorbidity. One study reported the association between perirenal fat weight and atherosclerosis, while the remaining articles measured PRFT. The pooled estimated OR among 4767 adults was 1.24 (1.06–1.45) with I² = 83.6%. Among 929 adults, the pooled correlation coefficient (r) was 0.412 (p < 0.0001, I² = 63.3%). Among 1221 children, it was 0.291 (p < 0.0001, I² = 0%). Conclusion: PRFT is significantly associated with carotid intima-media thickness, suggesting its potential as a non-invasive biomarker of atherosclerosis. Further large-scale, longitudinal studies are needed to confirm its predictive value.

30 December 2023 in International Journal of Endocrinology and Metabolism
Verified
Journal Article
Open access
PDF file
ACAbdolreza Chary
Abdolreza Chary
MTMaryam Tohidi
Maryam Tohidi
MHMitra Hasheminia
Mitra Hasheminia
MGMelika Golmohammadi
Melika Golmohammadi
RHReza Haji Hosseini
Reza Haji Hosseini
FHFarzad Hadaegh
Farzad Hadaegh
Background: The contribution of high-density lipoprotein cholesterol (HDL-C) subclasses to incident cardiovascular disease (CVD) and coronary heart disease (CHD) remains a subject of debate. Objectives: The objective of this study was to investigate these associations in a population with a high prevalence of dyslipidemia and CVD. Methods: In a nested case-control study, HDL-C and its subclasses (HDL2-C and HDL3-C) in 370 age and gender-matched case and control subjects were determined. This study employed multivariable-adjusted conditional logistic regression to calculate the odds ratios (ORs) for the associations between HDL-C, HDL2-C, HDL3-C, and HDL2-C/HDL3-C (both as continuous and categorical variables) with incident CVD and CHD. The present study models were adjusted for a comprehensive set of confounders, including body mass index, current smoking, hypertension, type 2 diabetes mellitus, use of lipid-lowering drugs, family history of premature CVD, non-HDL-C, and triglycerides. Results: In multivariate analysis, when considering lipoprotein parameters as continuous variables, a 1-unit increase in HDL-C and HDL3-C was associated with a reduced risk of incident CVD and CHD. For CVD, the ORs (95% confidence intervals [CI]) were 0.95 (0.92 - 0.98) and 0.95 (0.93 - 0.98) for HDL-C and HDL3-C, respectively. The corresponding values for CHD were 0.94 (0.91 - 0.97) and 0.94 (0.91 - 0.97). In the categorical approach to lipoprotein parameters, higher quartiles of HDL-C and HDL3-C, compared to the first quartile, were significantly associated with a lower risk of incident CVD and CHD. The ORs (95% CI) for the fourth quartiles were 0.43 (0.25 - 0.74, P for trend = 0.003) and 0.46 (0.27 - 0.78, P for trend = 0.005) for HDL-C and HDL3-C regarding CVD and 0.32 (0.17 - 0.59) and 0.32 (0.18 - 0.59) (all P for trend = 0.001) regarding CHD, respectively. Paradoxically, across quartiles of HDL2-C/HDL3-C, this lipid ratio was associated with a higher risk of CHD (92% higher risk in the fourth quartile). Conclusions: The results showed that HDL3-C, but not HDL2-C, was primarily responsible for the protective effect of HDL-C against CVD, particularly CHD, in Iranian adults.

9 November 2026 in Clinical Cardiology
Verified
Journal Article
Open access
MZMohammad Javad Zibaeenezhad
Mohammad Javad Zibaeenezhad
AAAlireza Arzhangzadeh
Alireza Arzhangzadeh
MSMehrab Sayadi
Mehrab Sayadi
AKAlireza Khodadadiyan
Alireza Khodadadiyan
MGMelika Golmohammadi
Melika Golmohammadi
MJMasih Jamshidi
Masih Jamshidi
Background: Atherosclerotic cardiovascular disease (ASCVD) remains a major global cause of morbidity and mortality, with obesity as a critical contributor. Traditional measures like body mass index (BMI) do not fully capture fat distribution or composition. Anthropometric and fat indices such as body fat (BF), may offer greater precision in ASCVD risk assessment. Methods: We analyzed data from 1106 university individuals (26−72 years). The primary analysis included adults 40−70 years ( n = 761), for whom 10‐year ASCVD risk was estimated using the 2019 ACC/AHA Pooled Cohort Equations (PCE). We modeled continuous risk using sex‐adjusted linear regression with each index entered separately and We tested Index × Sex interactions. Discrimination for elevated risk (≥7.5%) was assessed with ROC/AUC. A secondary analysis in participants <40 years assessed discrimination for a composite high risk‐factor burden endpoint (≥2 abnormalities among BP, lipids, smoking, diabetes, BMI). Results: The median (IQR) of ASCVD risk score was 1.33 (0.55−3.77), significantly higher in men than women (2.67 vs. 0.65; p < 0.001). Most participants (73.1%) were classified as low‐risk, though men had greater representation in higher‐risk categories. Furthermore, BF, Waist‐to‐height ratio (WHtR), and Waist‐to‐hip ratio (WHR) showed the strongest positive associations with continuous PCE risk, whereas Fat‐free mass (FFM) was inversely associated ( p < 0.001). For discriminating ≥7.5% risk, WHR performed best, BF and WC were modest and WHtR and BMI provided little to no discriminative ability. Conclusion: Anthropometric indices such as WC, WHR, and BF are valuable discriminators of ASCVD risk, surpassing BMI in risk assessment and stratification.

1 October 2025 in Urology Case Reports
Verified
Journal Article
Open access
FAFarzaneh Sharifi Aghdas
Farzaneh Sharifi Aghdas
MGMelika Golmohammadi
Melika Golmohammadi
NMNastaran Mahmoudnejad
Nastaran Mahmoudnejad
PTPeyman M. Torbati
Peyman M. Torbati
NSNiloofar Soleimanifard
Niloofar Soleimanifard
Paraurethral leiomyoma is a rare, benign smooth muscle tumor that often presents with urinary and pelvic symptoms, mimicking other periurethral conditions. We report a 41-year-old woman with pelvic pain and lower urinary tract symptoms, diagnosed with paraurethral leiomyoma and confirmed histologically. Although preoperative assessments may suggest an abdomino-vaginal approach, our case highlights that the surgical route is best determined intraoperatively. To better understand this condition, we reviewed published cases over recent decades, summarizing clinical presentations, diagnostic methods, surgical approaches, and postoperative outcomes.